6.06
Adapthealth Corp stock is traded at $6.06, with a volume of 2.08M.
It is up +3.59% in the last 24 hours and up +7.26% over the past month.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
See More
Previous Close:
$5.85
Open:
$5.95
24h Volume:
2.08M
Relative Volume:
0.81
Market Cap:
$808.46M
Revenue:
$3.24B
Net Income/Loss:
$-66.64M
P/E Ratio:
-11.42
EPS:
-0.5308
Net Cash Flow:
$219.38M
1W Performance:
-6.63%
1M Performance:
+7.26%
6M Performance:
-37.85%
1Y Performance:
-36.41%
Adapthealth Corp Stock (AHCO) Company Profile
Name
Adapthealth Corp
Sector
Industry
Phone
610-424-4515
Address
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AHCO
Adapthealth Corp
|
6.06 | 808.46M | 3.24B | -66.64M | 219.38M | -0.5308 |
|
ABT
Abbott Laboratories
|
101.95 | 176.41B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
90.96 | 116.35B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.56 | 105.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
42.98 | 62.29B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
84.37 | 48.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| May-10-23 | Downgrade | Deutsche Bank | Buy → Hold |
| May-10-23 | Downgrade | Stifel | Buy → Hold |
| May-09-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Jul-14-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-13-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-18-21 | Initiated | Truist | Buy |
| Jan-26-21 | Initiated | BofA Securities | Buy |
| Dec-10-20 | Initiated | UBS | Buy |
| Aug-10-20 | Initiated | Canaccord Genuity | Buy |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-09-20 | Initiated | RBC Capital Mkts | Outperform |
| Jan-31-20 | Initiated | Stifel | Buy |
| Jan-07-20 | Initiated | Jefferies | Buy |
| Dec-11-19 | Initiated | SVB Leerink | Outperform |
| Dec-10-19 | Initiated | Deutsche Bank | Buy |
View All
Adapthealth Corp Stock (AHCO) Latest News
AdaptHealth To Participate in Upcoming Investor Conferences - Yahoo Finance
Truist reiterates Buy on AdaptHealth stock after CFO change By Investing.com - Investing.com South Africa
People on the Move: Harriss Currie Named Chief Financial Officer of AdaptHealth - BioBuzz
Why AdaptHealth (AHCO) Stock Is Down Today - finance.yahoo.com
AdaptHealth (NASDAQ: AHCO) Appoints Harriss Currie as CFO with $670,000 Salary and $818K in Stock Units - Kalkine Media
Price-Driven Insight from (AHCO) for Rule-Based Strategy - Stock Traders Daily
AdaptHealth Names Chief Financial Officer - marketscreener.com
AdaptHealth (AHCO) taps new CFO with $670,000 salary - Stock Titan
AdaptHealth names Harriss Currie as chief financial officer - Investing.com
AdaptHealth names Harriss Currie as chief financial officer By Investing.com - Investing.com India
A new finance chief takes over Sept. 9; the current CFO helps through Oct. 1 at AdaptHealth. - Stock Titan
Adapthealth Stock Price Forecast. Should You Buy AHCO? - StockInvest.us
AdaptHealth sets Q2FY26 earnings release date for August 4 - scanx.trade
Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO) - Yahoo Finance
AdaptHealth Tries To Reset After A Tough 2026 - Finimize
Responsive Playbooks and the AHCO Inflection - Stock Traders Daily
Grabar Law Office Investigates Claims on Behalf of Long-term Shareholders of Adapthealth Corp. (AHCO) as Securities Fraud Class Case Heads to Settlement Mediation - TMX Newsfile
AdaptHealth Wins First OK For $14.3M NC Overbilling Deal - Law360
Bronstein, Gewirtz & Grossman, LLC Encourages AdaptHealth Corp. (AHCO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth C - The National Law Review
AdaptHealth (NASDAQ:AHCO) Faces Pressure After Weak Quarterly Results - kalkinemedia.com
AdaptHealth breach exposed health records of one in 13 Vermonters - Vermont Daily Chronicle
AdaptHealth Breach Exposed Health Records of One in 13 Vermonters - Compass Vermont
AdaptHealth Corp. (NASDAQ:AHCO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AdaptHealth (AHCO) Closing Note: Falls 1.12% to $5.75 in the Current Update; Boundary Check - Vinanet
AdaptHealth's Market Cap Drops To US$696m Leaving Insiders With Losses - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. (AHCO) Q2 2026 Earnings: EPS Misses Estimates by 48.1% on Unreported RevenueNet Profit Margin - vinanet.vn
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Investors to Learn More About the Investigation | NDAQ:AHCO | Press Release - Stockhouse
AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
AdaptHealth Corp. (AHCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of ... - Caledonian Record
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information - GlobeNewswire
AdaptHealth Director Dale B. Wolf Updates Stock Purchase Price in Amended SEC Filing - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect - ACCESS Newswire
Kenneth Samet Bought 94% More Shares In AdaptHealth - webull.com
5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call - Yahoo Finance
AdaptHealth Corp. (AHCO) Stock Forecasts - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages AdaptHealth Corp - The National Law Review
AdaptHealth misses Q2 revenue and earnings esti... - Pluang
AdaptHealth Corp. (AHCO) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Time To Worry? Analysts Just Downgraded Their AdaptHealth Corp. (NASDAQ:AHCO) Outlook - webull.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
AdaptHealth | 8-K: ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2026 RESULTS - Moomoo
AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript - AOL.com
AdaptHealth (NASDAQ:AHCO) Trading Up 10.5% on Insider Buying Activity - MarketBeat
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth - Yahoo Finance
AdaptHealth at Canaccord Genuity’s 46th annual growth conference: refocus deepens - Investing.com
AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 75% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Adapthealth Corp Stock (AHCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adapthealth Corp Stock (AHCO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WOLF DALE B | Director |
Aug 06 '26 |
Buy |
6.37 |
20,000 |
127,400 |
143,234 |
| WOLF DALE B | Director |
Aug 07 '26 |
Buy |
5.86 |
20,000 |
117,200 |
34,000 |
| Schuster III Russell E. | Chief Commercial Officer |
Jul 01 '26 |
Sale |
10.44 |
11,275 |
117,711 |
125,263 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):